Navigation Links
Whistleblower's extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
Date:10/25/2012

esult in recoveries for the government are entitled to a reward of 15 percent to 25 percent of the recovery. For the work Heiden and his attorneys did on the case, the government is awarding Heiden over 21 percent.

The allegations involved the off-label marketing of four drugs: Aggrenox, Atrovent, Combivent and Micardis. Pharma companies are prohibited from marketing drugs for uses the U.S. Food and Drug Administration (FDA) hasn't approved, although doctors may prescribe drugs for off-label uses.

The more egregious off-label marketing charges in the whistleblower lawsuit against Boehringer Ingelheim include:

  • Promoting the use of Aggrenox as one of the best drugs to reduce the risk of heart attacks and other cardiovascular risks despite the lack of evidence to support those claims. Aggrenox had been approved by the FDA only for prevention of secondary stroke.
  • Promoting the use of Atrovent and Combivent by children to treat asthma and coughs associated with a cold or flu, when the drugs had not been tested on kids, and promoting the use of excessively high, unapproved doses of Atrovent and Combivent in patients where only lower dosages were approved and considered safe.
  • Marketing Micardis for prevention of "metabolic syndrome" (medical conditions, such as insulin resistance, that increase the risk for heart disease and stroke) and prevention of early kidney disease when the FDA had approved Micardis only for treatment of hypertension.

"I was concerned that doctors were basing their treatment decisions on false information," Heiden said. "Promoting off-label treatments with potential serious consequences just to increase sales is heinous behavior."

"Boehringer Ingelheim's alleged off-label marketing practices helped it grow from a small company to one of the largest, privately held companies in the world," said Peter Chatfield, a Washington, DC, attorney with Phillips &a
'/>"/>

SOURCE Phillips & Cohen LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
2. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
3. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
4. Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research
5. Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
6. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
7. Neuralstem to Raise $7.0 Million in Registered Direct Offering
8. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
9. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
10. Henry Schein Announces New $500 Million Credit Facility
11. Philips ermöglicht noch besseren Zugang zu Behandlungen für häufige Todesursache in den USA durch Bereitstellung seines einmillionsten AED
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  The recent ... health plans and employer groups scrambling to identify ... a major managed care plan, retail pharmacy chain, ... Healthcare,s $13.3 billion purchase of Catamaran, Rite Aid,s ... announcement to purchase Omni-Care for $10 billion are ...
(Date:5/28/2015)... , May 28, 2015 The ... the Commission,s antitrust suit charging Cephalon, Inc. with ... drug Provigil. The settlement ensures that Teva Pharmaceutical ... make a total of $1.2 billion available to ... who overpaid because of Cephalon,s illegal conduct.  ...
(Date:5/28/2015)... May 28, 2015 Lungpacer Medical, Inc., ... phrenic-nerve-pacing system announced today that it will be ... on Thursday, June 4, 2015 in New York ... a.m. Eastern Time.   About Lungpacer ... preclinical stage medical device company pioneering the development ...
Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
(Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey has been ... by Congress to examine how to best deliver health ... commission by Mitch McConnell, majority leader of the U.S. ... voting members on the panel, which was established by ... The goal of the commission is to examine how ...
(Date:5/28/2015)... 2015 The Clinical Data Interchange ... the International Organization for Standardization (ISO) now recognizes ... Model version 3.2 as a published, Final International ... healthcare. This standard, which had previously passed through ... unanimously approved on 24 April for publication by ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will participate ... the strength, passion and endurance of those facing Alzheimer’s ... this sunrise-to-sunset event symbolizes the challenging journey of those ... funds and awareness to advance the care, support and ... encouraged to create their own experience as they fundraise ...
(Date:5/28/2015)... Calif. (PRWEB) May 28, 2015 Restricting ... prevent firearm violence, but policies that more clearly define ... to a review of existing research and public policies ... The analysis, published online April 30 in the peer-reviewed ... drinking and other forms of alcohol misuse in association ...
(Date:5/28/2015)... May 28, 2015 Three years ago, Dr. ... for his Shore Vascular & Vein Center! Dr. ... system. It is his mission to provide the highest ... , Dr. Jeffrey Gosin is Board Certified in ... University of Pennsylvania and Jefferson Medical College. He completed a ...
Breaking Medicine News(10 mins):Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3
... team of German and American researchers have used enetic ... ability to transmit malaria--at least to mice, new study ... the right direction" towards combating malaria in humans, study ... in Ohio. "We now know it is possible to ...
... According to researchers, doctors should begin evaluating people's risk ... levels, beginning at age 20, the American Heart Association ... heart attack and stroke. Thomas Pearson, chairman of the ... years,// and there certainly is an opportunity to make ...
... chocolate every day is connected to good mood and happy ... has long been seen as a pleasurable indulgence.// However, recent ... contains antioxidants, which can protect from chronic disease. ... who eat chocolate regularly are happier than those who do ...
... new study shows some cancer patients who also have ... the drug, interferon.,Past research has suggested a connection between ... //A patient with both of these diseases was treated ... researchers in Paris to study whether the treatment could ...
... women with high levels of lead in their bones face ... lead from sources like old pain, researchers reported recently. In ... of lead exposure// “may constitute a significant public health problem, ... bone.” ,The findings demonstrated that protecting children from the ...
... with medications can reduce abdominal fat in people with type ... looking into the effect that the drug Pioglitazone has on ... the condition, who took the drug for 16 weeks. ... But measurements revealed an interesting redistribution of body fat, inspite ...
Cached Medicine News:Health News: Gene researchers make Malaria-resistant mosquito 2Health News:Heart attack risk starts at 20 2
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... The XCell line of mini-cells has ... sturdy and convenient. The tradition continues ... The incorporation of a gel tension ... wedge used on earlier models makes ...
... is built upon the success of the ... automates all thermal and wash cycles for ... glass slides. A 4-position GeneMachines Hyb4 ... the individual ports allow for independent probe ...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Medicine Products: